Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine, launched in the U.S. in November to high awareness and demand GW moves to a new fiscal year-end beginning January 1,... read more →
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2019) - Tidal Royalty Corp. (CSE: RLTY.U) ("Tidal" or the "Company") is pleased to announce that, further to its press release of February... read more →
New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora's International Footprint to 24 Countries EDMONTON, Feb. 26, 2019 /PRNewswire/ - Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN:... read more →
Company intends to capitalize on legalized segment of European cannabis market with its popular CBD tinctures and vape product line as part of its international execution strategy Ignite International Brands, Ltd. (CSE:... read more →
Supply agreement cements Organigram's position as a national leader in Canada's recreational cannabis marketplace MONCTON, NB, Feb. 26, 2019 /PRNewswire/ - Organigram Holdings Inc. (TSXV: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the... read more →
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) ("TCAN" or the "Company"), is a Canadian based company providing branding, transportation, and distribution... read more →
Sky and Bradford Facilities Combine for Over 128,000 kg per Year Production Capacity EDMONTON, Feb. 25, 2019 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P;... read more →
